View the Novel Agents and Clinical Trials Teleconference Now
Dr. Craig Cole (University of Michigan Comprehensive Cancer Center) gives an update on the novel agents currently used to treat multiple myeloma and how clinical trials benefit patients.
This teleconference is sponsored by an educational grant from:
Celgene Corporation and Janssen